Delivery Order 75N98026D00031-75N98026F00001
Award Date 7/20/26
Potential Completion Date 1/19/28
Potential Value $383K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on July 20, 2026, with a ceiling value of $478,052, under a cost-plus-fixed-fee pricing structure for a Phase 1 single ascending dose pharmacokinetics study of parent and metabolite compounds as part of the Analytical Services Center for Medications Development. Place of performance is Kansas City, Missouri. The order extends through January 19, 2028. The delivery order...
- The National Institute on Drug Abuse issued a $1,838,614.86 delivery order to Altasciences Clinical Kansas Inc. on September 25, 2023, for pharmacokinetic and pharmacodynamic trials supporting Phase 1 cocaine drug interaction studies in medication development for substance use disorders. The order runs through October 22, 2025. Place of performance is Shawnee Mission, Kansas. The delivery order is priced on a firm fixed-price basis and was issued under a $21 million single-award indefinite...
- This is a $5,108,214.00 cost-plus-award-fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) with an ultimate completion date of September 18, 2029. Mriglobal has been awarded multiple significant federal contracts and grants, including Indefinite Delivery Contracts...
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc. on May 15, 2025, with a ceiling value of $487,769, for pharmacokinetic analysis and Phase I single ascending dose study support under a cost-plus-fixed-fee arrangement. Technical Resources International is a minority-owned, woman-owned, and Hispanic American-owned small business. The order is issued under a $2.5 million Indefinite Delivery Vehicle (IDV) with NIDA for pharmacokinetic analysis...
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc. on July 23, 2025, with a ceiling value of $11,079.00 for pharmacokinetic analysis resource center support under a Phase I clinical pharmacology/pharmacokinetic study. The order is issued under a $2.5 million IDV with NIDA for pharmacokinetic analysis. Technical Resources International is a minority-owned, woman-owned, and Hispanic American-owned small business. Place of performance is...
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc. on July 23, 2025, with a ceiling value of $36,099.00 under a cost-plus-fixed-fee pricing structure. The order is issued under a $2.5 million IDV with NIDA for pharmacokinetic analysis. Technical Resources International is a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland, specializing in clinical research support services to federal health...
- <p>The National Institute on Drug Abuse issued a purchase order to Labcorp Early Development Laboratories Inc. valued at $108,254.16 on July 1, 2023, for completion of pharmacokinetics for the MAD portion of the RR-HNK Phase 1 study under the FY26 UDO initiative. Work is performed in Madison, Wisconsin. The order carries a firm fixed price structure and was not set-aside. Ultimate completion date was June 30, 2025.</p>
- The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...
- The National Institute on Drug Abuse (NIDA) awarded a $249,093.62 firm fixed-price delivery order to Eurofins Discovery Services North America, LLC on September 21, 2025, for receptor profile screening services. The contract runs through September 20, 2026, and represents work performed at the contractor's facility in St. Peters, Missouri. This delivery order is issued under NIDA's existing $5 million Indefinite Delivery Vehicle (IDV) for receptor binding and predictive toxicology services,...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO). The $1,340,461.88 firm fixed-price delivery order is for a clinical trial to assess the safety, tolerability, and pharmacokinetics of an investigational agent for substance use disorder (SUD) treatment. The contract is part of NIDA's $21 million indefinite delivery contract N01DA-23-8935, which supports...